Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Grant or award Director acquired 37,160 shares (grant or award)
  2. 4 Grant or award President & GM China acquired 1,149,899 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Chief Executive Officer acquired 574,938 shares (grant or award)
  5. 3/A Insider 3/A
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale CFO & Chief Strategy Officer sold 40,000 shares at an average $160.27 ($6,410,651)
  9. 4 Open-market sale Chief Executive Officer sold 99,000 shares at an average $145.63 ($14,416,931)
  10. 4 Open-market sale EVP and Gl. Head of Bus. Dev. sold 10,000 shares at an average $146.88 ($1,468,760)
  11. 5 Insider Annual Insider Trading Report
  12. 5 Insider Annual Insider Trading Report
  13. 4/A Insider Changes in Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 1,980,198 shares at $101.00 ($199,999,998)
  16. 4 Open-market sale Chief Executive Officer sold 20,137 shares at an average $96.46 ($1,942,515)
  17. 4 Open-market sale CMO, Hematology sold 1,000 shares at $98.00 ($98,000)
  18. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $94.25 ($141,381)
  19. 4 Open-market sale Chief Executive Officer sold 144,000 shares at an average $93.95 ($13,529,286)
  20. 4 Open-market sale CMO, Hematology sold 1,100 shares at $86.00 ($94,600)

Page 25 of 29 · 580 filings